Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...
A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...
The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and schizophrenia research. The ...
A U.S. Centers for Medicare & Medicaid Services 18-month trial program will offer for the first time Novo Nordisk’s Wegovy ...
Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...
The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...
The presidential fitness test is back, surprising new data on the health risks of obesity, and more Morning Rounds news ...
Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...
Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...
Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...
CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results